Detalhe da pesquisa
1.
Integration of Genomic Sequencing Drives Therapeutic Targeting of PDGFRA in T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma.
Clin Cancer Res
; 29(22): 4613-4626, 2023 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37725576
2.
Targeting serine hydroxymethyltransferases 1 and 2 for T-cell acute lymphoblastic leukemia therapy.
Leukemia
; 36(2): 348-360, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34341479
3.
An In Vivo CRISPR Screening Platform for Prioritizing Therapeutic Targets in AML.
Cancer Discov
; 12(2): 432-449, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34531254
4.
Unleashing Cell-Intrinsic Inflammation as a Strategy to Kill AML Blasts.
Cancer Discov
; 12(7): 1760-1781, 2022 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35405016
5.
EP300 Selectively Controls the Enhancer Landscape of MYCN-Amplified Neuroblastoma.
Cancer Discov
; 12(3): 730-751, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34772733
6.
Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1.
Nat Cancer
; 3(8): 976-993, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35817829
7.
Selective Modulation of a Pan-Essential Protein as a Therapeutic Strategy in Cancer.
Cancer Discov
; 11(9): 2282-2299, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33883167
8.
STAG2 loss rewires oncogenic and developmental programs to promote metastasis in Ewing sarcoma.
Cancer Cell
; 39(6): 827-844.e10, 2021 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34129824
9.
Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory, or High-Risk Leukemias: A Report from the LEAP Consortium.
Cancer Discov
; 11(6): 1424-1439, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33563661
10.
A Combination CDK4/6 and IGF1R Inhibitor Strategy for Ewing Sarcoma.
Clin Cancer Res
; 25(4): 1343-1357, 2019 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30397176
11.
Genome-scale CRISPR-Cas9 screen identifies druggable dependencies in TP53 wild-type Ewing sarcoma.
J Exp Med
; 215(8): 2137-2155, 2018 08 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30045945
12.
Resistance to Epigenetic-Targeted Therapy Engenders Tumor Cell Vulnerabilities Associated with Enhancer Remodeling.
Cancer Cell
; 34(6): 922-938.e7, 2018 12 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30537514
13.
Targeting EZH2 for the treatment of hepatosplenic T-cell lymphoma.
Blood Adv
; 4(7): 1265-1269, 2020 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32232478